Genome
10 known investors
Genome Medical provides telehealth-enabled genetic services, including counseling, testing, and clinical trial access, primarily for individuals with rare conditions. The company partners with hospitals, health systems, and life sciences organizations to expand access to expert genetic guidance.
Investors · 10
Canaan PartnersStamford · $500K – $20M
Dreamers VCEl Segundo · $500K – $5M
Echo Health VenturesDurham
GV (Google Ventures)Mountain View · $250K – $50M
Illumina VenturesFoster City
Kaiser Permanente VenturesSan Francisco · $2M – $5M
Samsung Catalyst FundSan Jose
Walden CatalystSan Francisco · $550K
LRVHealthreportedBoston · $500K – $1M
Novo HoldingsreportedCopenhagen · $1.1M – $54M
In the news
- MedGenome Raises $50M To Map The Human Genomenews.crunchbase.com · 2022
- Genome Insight Raises $23M in Series B Fundingfinsmes.com · 2022
- Genome Medical plots growth spurt with back-to-back $60M venture raise, GeneMatters acquisition | Fierce Biotechfiercebiotech.com · 2021
- Genome Medical Raises $14M in Funding - FinSMEsfinsmes.com · 2020
- Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Developmentprnewswire.com · 2020